11 results
P
lung disease, li, ipf
I/C
baicalin, no intervention
O
reduced inflammation, decreased apoptosis, protected against progression
P
patients with liver lesions
I/C
LI-RADS algorithm, original studies reporting probability of LR-M for HCC and non-HCC malignancy on MRI
O
pooled percentages of HCC and non-HCC malignancy for LR-M, sources of heterogeneity between reported results
P
Lin and colleagues
I/C
sodium-glucose cotransporter 2 inhibitors (SGLT2is), use of SGLT2is vs. non-use
O
occurrences of various kinds of serious adverse events (AE)
P
Zeng BS, Lin SY, Tu YK, et al
I/C
Prevention of Postdental Procedure Bacteremia
O
J Dent Res 2019 Oct;98(11):1204-1210
P
Li QL, Yao MF, Cao RY, Zhao K, Wang XD
I/C
short dental implants, splinted and nonsplinted prostheses
O
survival rates
P
Hu ML, Zheng G, Lin H, Yang M, Zhang YD, Han JM
I/C
Desensitizing Toothpastes
O
Dentine Hypersensitivity
P
Individuals participating in blood flow restriction (BFR) training
I/C
BFR training, High-intensity resistance training (HIRT)
O
Muscular strength, hypertrophy, and endurance
P
red yeast rice preparations
I/C
RYR preparations, control treatments
O
adverse health outcomes
P
Orthodontic-surgical treatment patients
I/C
Conventional combined orthodontic-surgical treatment, No treatment or alternative treatments
O
Oral health-related quality of life
P
chronic liver disease, hepatitis C, hepatitis B
I/C
antiviral therapy, hepatitis B, hepatitis C
O
health utility scores